PALO ALTO, Calif., and
SINGAPORE, May 7, 2020 /PRNewswire/ -- Varian (NYSE:
VAR) and the National University Cancer
Institute, Singapore (NCIS), are
partnering to expand access to cancer solutions in Singapore in the fight against cancer. In
2018, 26,164 cases of cancer were diagnosed in Singapore, and it is expected to more than
double to 57,319 cases over the next 20 years.1
Two Varian VitalBeam™ medical linear accelerators,
together with an Edge™ radiosurgery system with
HyperArc™ technology, will be installed at NCIS, thereby
expanding radiation therapy treatment options for cancer patients
in Singapore.
Dr Francis Ho, head of the
Department of Radiation Oncology at NCIS said: "We are proud to
continue bringing in innovative therapy treatments, such as
HyperArc, to help treat patients with cancer. We are committed to
providing quality patient care to the people in Singapore. With this technology, we hope to
reduce inefficiencies in plan creation and treatment delivery,
leading to reduced treatment times for patients."
Kenneth Tan, president, Varian
Asia Pacific said: "With an ever-rising number of patients being
diagnosed with cancer and an increasingly aging population, it is
now more important than ever to help patients and clinicians in
Singapore in the fight against
cancer. Through this partnership with the National University Cancer Institute, Singapore, and by bringing in high-quality
radiation therapy combined with connected cancer care solutions, we
are working towards our vision of living in a world without fear of
cancer."
HyperArc technology is designed to automate and simplify
sophisticated treatments such as stereotactic radiosurgery (SRS)
and make them available to more cancer patients around the world.
VitalBeam offers high-quality, high-throughput radiation therapy,
which enables healthcare professionals to expand clinical
capabilities and serve more patients with advanced treatment
technology over time.
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 10,000 employees across 70 locations
keep the patient and our clinical partners at the center of our
thinking as we power new victories in cancer care. Because, for
cancer patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
1 International Agency for Research on Cancer 2018:
Last accessed 15 January 2019.
https://gco.iarc.fr/tomorrow/graphic-isotype?type=0&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0
Press Contact
Christine
Hogseth-Gill
Head of Public Affairs, Asia
Pacific and Japan
+65 93881352
christine.hogseth-gill@varian.com
Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/center-in-singapore-expanding-access-to-radiation-therapy-technology-in-the-fight-against-cancer-301054733.html
SOURCE Varian